Jeffrey Berkowitz
- Role
-
Board member
Elected to the Board in 2019 and regarded as an independent board member.
- Member of the Audit Committee
Special competencies
Global executive with extensive branded and generic pharmaceutical, retail pharmacy, wholesale drug distribution, speciality, payor and healthcare services leadership experience in P&L accountable roles.
Current positions
CEO and Director of Real Endpoints. Board member of H. Lundbeck A/S, Esperion Therapeutics, Inc. and Uniphar PLC.